JESSICA PFEIFER: Open Payments
NPI 1659949089 · LANCASTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,698 in 163 payments from 21 companies in 2025. Trend: 2023 $3,050 · 2024 $4,662 · 2025 $2,698
Food & beverage: $2,598Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $473 |
| UCB, Inc. | 20 | $323 |
| ABBVIE INC. | 28 | $322 |
| GENZYME CORPORATION | 10 | $286 |
| Galderma Laboratories, L.P. | 20 | $222 |
| PFIZER INC. | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 33 | $181 |
| Organon LLC | 5 | $104 |
| Lilly USA, LLC | 5 | $96 |
| LEO Pharma Inc. | 3 | $67 |
Products named: TREMFYA, Bimzelx, DUPIXENT, CIBINQO, SKYRIZI, RINVOQ, NEMLUVIO, AYVAKIT.
Industry payments across NY — which companies pay providers there.
